1. Home
  2. III vs VYGR Comparison

III vs VYGR Comparison

Compare III & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • III
  • VYGR
  • Stock Information
  • Founded
  • III 2006
  • VYGR 2013
  • Country
  • III United States
  • VYGR United States
  • Employees
  • III N/A
  • VYGR N/A
  • Industry
  • III Professional Services
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • III Consumer Discretionary
  • VYGR Health Care
  • Exchange
  • III Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • III 171.3M
  • VYGR 165.5M
  • IPO Year
  • III 2007
  • VYGR 2015
  • Fundamental
  • Price
  • III $4.83
  • VYGR $3.29
  • Analyst Decision
  • III Buy
  • VYGR Strong Buy
  • Analyst Count
  • III 1
  • VYGR 8
  • Target Price
  • III $5.50
  • VYGR $14.33
  • AVG Volume (30 Days)
  • III 230.3K
  • VYGR 545.6K
  • Earning Date
  • III 05-08-2025
  • VYGR 05-06-2025
  • Dividend Yield
  • III 3.73%
  • VYGR N/A
  • EPS Growth
  • III N/A
  • VYGR N/A
  • EPS
  • III 0.16
  • VYGR N/A
  • Revenue
  • III $242,899,000.00
  • VYGR $66,958,000.00
  • Revenue This Year
  • III N/A
  • VYGR N/A
  • Revenue Next Year
  • III $5.05
  • VYGR $45.34
  • P/E Ratio
  • III $30.79
  • VYGR N/A
  • Revenue Growth
  • III N/A
  • VYGR N/A
  • 52 Week Low
  • III $2.92
  • VYGR $2.65
  • 52 Week High
  • III $5.05
  • VYGR $9.55
  • Technical
  • Relative Strength Index (RSI)
  • III 64.11
  • VYGR 52.90
  • Support Level
  • III $4.60
  • VYGR $2.65
  • Resistance Level
  • III $4.87
  • VYGR $2.99
  • Average True Range (ATR)
  • III 0.18
  • VYGR 0.21
  • MACD
  • III -0.03
  • VYGR -0.01
  • Stochastic Oscillator
  • III 56.86
  • VYGR 59.26

About III Information Services Group Inc.

Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: